<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(1)</volume><submitter>Alkhormani AA</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Post-COVID-19 syndrome refers to a variety of symptoms that affect different organs in the body and can persist 28 days following exposure to COVID-19. Previous studies have shown that COVID-19 affects not only elderly individuals but also young adults. However, the influence of post-COVID-19 syndrome on young adults has not been studied sufficiently. Therefore, the aim of this study was to determine the prevalence and characteristics of post-COVID-19 manifestations in young adults.&lt;h4>Methods&lt;/h4>An analytical cross-sectional online questionnaire was distributed from July 2022 to July 2023 to health sciences students in Saudi Arabia. The study used a non-probability convenience sampling technique, and the sample size was calculated to be 464. The survey included questions about the participants' demographics, health records, COVID-19 results, duration of infection, and previous and current COVID-19 symptoms. Illness severity and management were evaluated using the COVID Experiences (COVEX) Symptoms and Diagnoses module, and Patient Health Questionnaire (PHQ-9) was used to assess depression.&lt;h4>Results&lt;/h4>According to the inclusion criteria, 428 participants were divided into three groups: those who fully recovered within 14 days of the acute phase (76.4%), those with prolonged symptoms that resolved within 28 days (16.8%), and those with persistent symptoms for more than 28 days (6.8%). The symptom development frequency during the acute phase significantly differed among the three groups: headache (p = 0.038), loss of smell and taste (p = &lt; 0.001), and fatigue (p = 0.009). The symptoms that significantly differed between the prolonged group and persistent group during the post-COVID-19 syndrome phase were loss of smell and taste (p = &lt; 0.001) and shortness of breath (p = &lt; 0.001). The study results revealed that females are susceptible to long-COVID-19. This study revealed that the overall severity of post-COVID-19 symptoms was mild in this age group. The PHQ-9 score when comparing the three groups showed a significant association with depression (p = 0.035).&lt;h4>Conclusion&lt;/h4>The study results support the perception that not only can the geriatric population suffer from post-COVID-19 syndrome but also that young adults are prone to persistent symptoms such as loss of smell and taste, which may affect their mental health status.</pubmed_abstract><journal>BMC public health</journal><pagination>3613</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11684266</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Post-COVID-19 manifestations among college students: shedding the light on young adults' health.</pubmed_title><pmcid>PMC11684266</pmcid><pubmed_authors>Alamri FF</pubmed_authors><pubmed_authors>Alkhormani AA</pubmed_authors><pubmed_authors>Alghamdi RA</pubmed_authors><pubmed_authors>Damdam YA</pubmed_authors><pubmed_authors>Almaghrabi ME</pubmed_authors><pubmed_authors>Khan MA</pubmed_authors><pubmed_authors>Hakami AY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Post-COVID-19 manifestations among college students: shedding the light on young adults' health.</name><description>&lt;h4>Background&lt;/h4>Post-COVID-19 syndrome refers to a variety of symptoms that affect different organs in the body and can persist 28 days following exposure to COVID-19. Previous studies have shown that COVID-19 affects not only elderly individuals but also young adults. However, the influence of post-COVID-19 syndrome on young adults has not been studied sufficiently. Therefore, the aim of this study was to determine the prevalence and characteristics of post-COVID-19 manifestations in young adults.&lt;h4>Methods&lt;/h4>An analytical cross-sectional online questionnaire was distributed from July 2022 to July 2023 to health sciences students in Saudi Arabia. The study used a non-probability convenience sampling technique, and the sample size was calculated to be 464. The survey included questions about the participants' demographics, health records, COVID-19 results, duration of infection, and previous and current COVID-19 symptoms. Illness severity and management were evaluated using the COVID Experiences (COVEX) Symptoms and Diagnoses module, and Patient Health Questionnaire (PHQ-9) was used to assess depression.&lt;h4>Results&lt;/h4>According to the inclusion criteria, 428 participants were divided into three groups: those who fully recovered within 14 days of the acute phase (76.4%), those with prolonged symptoms that resolved within 28 days (16.8%), and those with persistent symptoms for more than 28 days (6.8%). The symptom development frequency during the acute phase significantly differed among the three groups: headache (p = 0.038), loss of smell and taste (p = &lt; 0.001), and fatigue (p = 0.009). The symptoms that significantly differed between the prolonged group and persistent group during the post-COVID-19 syndrome phase were loss of smell and taste (p = &lt; 0.001) and shortness of breath (p = &lt; 0.001). The study results revealed that females are susceptible to long-COVID-19. This study revealed that the overall severity of post-COVID-19 symptoms was mild in this age group. The PHQ-9 score when comparing the three groups showed a significant association with depression (p = 0.035).&lt;h4>Conclusion&lt;/h4>The study results support the perception that not only can the geriatric population suffer from post-COVID-19 syndrome but also that young adults are prone to persistent symptoms such as loss of smell and taste, which may affect their mental health status.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-04T02:48:24.554Z</modification><creation>2025-04-04T02:48:24.554Z</creation></dates><accession>S-EPMC11684266</accession><cross_references><pubmed>39736592</pubmed><doi>10.1186/s12889-024-20925-8</doi></cross_references></HashMap>